Compare · LUCY vs STAA
LUCY vs STAA
Side-by-side comparison of Innovative Eyewear Inc. (LUCY) and STAAR Surgical Company (STAA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LUCY and STAA operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- STAA carries a market cap of $3.18B.
- Both names hit the wire about 3 times in the past 4 weeks.
- STAA has more recent analyst coverage (25 ratings vs 0 for LUCY).
- Company
- Innovative Eyewear Inc.
- STAAR Surgical Company
- Price
- -
- -
- Market cap
- -
- $3.18B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2022
- News (4w)
- 3
- 3
- Recent ratings
- 0
- 25
STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Latest LUCY
- Innovative Eyewear, Inc. Announces Preliminary Q1 2026 Results
- Innovative Eyewear, Inc. Receives Red Dot Design Award on Lucyd Armor Smart Safety Glasses
- Innovative Eyewear, Inc. Announces New Reebok Optical Collection and Retail Placements
- Innovative Eyewear, Inc. Announces New Smart Safety Glasses and Rx Safety Partner
- Innovative Eyewear Inc. Reports Full Year 2025 Financial Results
- SEC Form 10-K filed by Innovative Eyewear Inc.
- Innovative Eyewear, Inc. Announces Q4 and Full Year 2025 Earnings Conference Call
- Innovative Eyewear, Inc. Announces New Distribution with Major European Retailer MODIVO Group
- Innovative Eyewear, Inc. Receives Notice of Patent Allowance for Smartglasses Charging Cradle
- Amendment: SEC Form SCHEDULE 13G/A filed by Innovative Eyewear Inc.
Latest STAA
- STAAR Surgical upgraded by Canaccord Genuity with a new price target
- STAAR Surgical Company filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- STAAR Surgical Announces Preliminary Net Sales for First Quarter 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by STAAR Surgical Company
- Interim Co-CEO and Pres. & COO Foust Warren converted options into 37,500 shares, increasing direct ownership by 144% to 63,588 units (SEC Form 4)
- SEC Form 4 filed by Interim Co-CEO and CFO Andrews Deborah J
- Chief Development Officer Michna Magda converted options into 23,773 shares and covered exercise/tax liability with 8,529 shares, increasing direct ownership by 105% to 29,668 units (SEC Form 4)
- Director Broadwood Partners, L.P. bought $12,266,545 worth of shares (670,213 units at $18.30) (SEC Form 4)
- SEC Form 4 filed by STAAR Surgical Company
- SEC Form 4 filed by Director Lebuhn Richard T.